November 12, 2026

@michaelokun

Can AI Diagnose Parkinson’s Disease? My Interview with Reid Hoffman’s AI Digital Twin. Will earlier be better and and give doctors more time to care for their patients? At the Masters of Scale Summit in Silicon Valley, I had a fascinating conversation with an AI digital twin of Reid Hoffman about the future of artificial intelligence in healthcare and how emerging technologies could transform the diagnosis and treatment of neurological diseases. - One of the most exciting developments we discussed was Neuropacs, an AI-powered technology that analyzes brain MRI scans to help distinguish Parkinson’s disease from conditions that can look remarkably similar, including progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). - Why does this matter? Getting the diagnosis right, and getting it right early, can change how we counsel patients, select treatments, plan care, and approach clinical trials. Parkinson’s disease, PSP, and MSA may share symptoms, but they are different diseases with different prognoses and treatment considerations. - What excites me most about AI is not the possibility of replacing physicians. It is the opportunity to make physicians better. If AI can help us interpret complex diagnostic information more efficiently, we can spend less time sorting through data and more time sitting with patients and families, explaining what the diagnosis means, answering questions, and developing a personalized plan. - The future of AI in medicine should not be about replacing the human connection. It should be about strengthening it. - Join me for this amazing conversation (with Reid's digital twin) about Parkinson’s disease, brain MRI, artificial intelligence, and the future of neurological care. https://youtube.com/shorts/3EwGLqc_Hn4?feature=share